Prevention of stroke and cancer: could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors?

Am J Hypertens. 1999 Oct;12(10 Pt 1):1050-3.

Authors

J M Achard¹, A Pruna, L A Fernandez, C Hottelart, H Mazouz, A Rosa, M Andrejak, A Fournier

Affiliation

¹ Service de Néphrologie, Médecine Interne, Hopital Sud, Amiens, France.

PMID: 10560795

No abstract available

Publication types

Review

MeSH terms

Angiotensin II / physiology
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Humans
Neoplasms / prevention & control*
Stroke / prevention & control*

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Angiotensin II